Clinical Trial Update: Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating prevention of cytomegalovirus infection in kidney transplant recipients using T gamma delta-CD16+ cells in combination with anti-CMV im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Cytomegalovirus Immunoglobulin (CMVIG) (immunoglobulin)
• Gamma-delta T cell therapy (CD16+) (gamma-delta T cells (CD16+))

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Kidney Transplantation, CMV Infection | Phase 2 | Status: COMPLETED